HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
H L Lenzi Selected Research
H L Lenzi Research Topics
Disease
4
Infections
03/2003 - 01/2000
2
Granuloma
09/2006 - 10/2002
1
Schistosomiasis (Bilharziasis)
09/2006
1
Fibrosis (Cirrhosis)
01/2001
1
Leprosy (Hansen's Disease)
06/2000
1
Neurologic Manifestations (Neurological Manifestations)
05/2000
1
Eosinophilia
01/2000
1
Pleurisy (Pleuritis)
01/2000
1
Edema (Dropsy)
01/2000
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
09/2006 - 01/2000
2
Antibodies
IBA
09/2006 - 10/2002
2
Immunoglobulin E (IgE)
IBA
03/2003 - 01/2000
2
Cytokines
IBA
06/2000 - 05/2000
1
Occludin
IBA
09/2006
1
Adenosine Triphosphate (ATP)
IBA
09/2006
1
Epitopes
IBA
09/2006
1
Apyrase (ATP Diphosphatase)
IBA
09/2006
1
Cadherins (E-Cadherin)
IBA
09/2006
1
Acetylcholine (Acetylcholine Chloride)
FDA Link
01/2003
1
Serotonin (5 Hydroxytryptamine)
IBA
01/2003
1
Reticulin (Reticular Fiber)
IBA
10/2002
1
Antigens
IBA
10/2002
1
Ovalbumin
IBA
10/2002
1
Pharmaceutical Preparations
IBA
01/2001
1
lipoxin A4
IBA
01/2000
1
Interleukin-5 (Interleukin 5)
IBA
01/2000
1
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
IBA
01/2000
1
Allergens
IBA
01/2000
1
Meloxicam (Mobic)
FDA Link
Generic
01/2000
1
4- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamide
IBA
01/2000
1
N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamide
IBA
01/2000
1
Dinoprostone (PGE2)
FDA Link
01/2000